熱門資訊> 正文
Omnicell任命Baird Radford为执行副总裁兼CFO
2025-08-26 04:12
- Omnicell (NASDAQ:OMCL) announced on Monday the appointment of Baird Radford as Executive Vice President and Chief Financial Officer, effective August 26, 2025.
- Radford succeeds Nchacha Etta, who will be stepping down from the role, as announced earlier this year. Etta will remain with the company in an advisory role through November 2025 to help ensure a smooth transition of responsibilities.
- Radford most recently served as Chief Financial Officer for Allakos, a biotechnology company focused on developing therapeutic antibodies.
- Prior to Allakos, Radford served as Senior Vice President of Finance for Aimmune Therapeutics, which was acquired by Nestle Health Sciences in late 2020, where he led all aspects of strategic and operational finance activities.
More on Omnicell
- Omnicell, Inc. 2025 Q2 - Results - Earnings Call Presentation
- Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript
- Omnicell Q2 Earnings: Market Ignoring The Segments
- Omnicell Q2 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Omnicell
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
